Skip to main content
. 2021 Mar 1;113(5):1168–1176. doi: 10.1093/ajcn/nqaa420

TABLE 2.

Baseline characteristics according to treatment assignment1

EPA+DHA (n = 138) Control (n = 130) P value
Demographic characteristics
 Age, y 62.9 ± 7.6 63.9 ± 7.4 0.27
 Male sex 115 (83.3) 108 (83.1) 0.82
 Diabetics 39 (28.3) 40 (30.8) 0.81
Anthropometrics and blood pressure
 Weight, kg 91.8 ± 13.6 90.2 ± 15.2 0.48
 BMI,2 kg/m2 30.8 ± 3.6 30.6 ± 3.7 0.66
 Waist, cm 106.9 ± 10.3 106.7 ± 11.2 0.71
 Systolic BP, mm Hg 125.1 ± 14.6 124.4 ± 14.8 0.88
 Diastolic BP, mm Hg 73.1 ± 10.0 72.4 ± 8.9 0.84
Biochemical profile
 HbA1c, % 6.1 ± 0.8 6.3 ± 1.1 0.27
 Glucose, mg/dL 104.8 ± 27.4 108.6 ± 37.3 0.29
Lipid concentrations,3 mg/dL
 Total cholesterol 152.5 ± 37.5 152.1 ± 34.0 0.76
 LDL-C 77.7 ± 26.9 78.2 ± 28.3 0.35
 HDL-C 47.2 ± 14.8 46.8 ± 14.4 0.72
 Triglyceride 121.5 [80.3–178.8] 114.0 [78.0–161.0] 0.44
Inflammatory markers
 hs-CRP, mg/L 1.0 [0.4–2.5] 1.0 [0.4–3.1] 0.08
 WBC, 109 cells/L 6.6 ± 2.0 6.6 ± 1.6 0.59
 Monocytes, cells/μL 542.3 ± 173.0 516.9 ± 170.7 0.16
 Neutrophils, cells/μL 4238.9 ± 1767.5 4192.4 ± 1341.1 0.74
 Lymphocytes, cells/μL 1629.9 ± 557.6 1694.6 ± 632.6 0.23
Medications
 Statin therapy 133 (96.4) 123 (94.6) 0.37
 Aspirin 133 (96.4) 124 (95.4) 0.53
1

Values are mean ± SD, n (%), or median [IQR]. Categorical variables (male sex and diabetes) were expressed as n (%) and compared using the chi-square test. All normally distributed continuous variables were compared using unpaired t tests except for triglyceride and hs-CRP, which were compared with the Wilcoxon–Mann–Whitney U test because they were nonnormally distributed variables. BP, blood pressure; HbA1C, glycated hemoglobin; HDL-C, HDL cholesterol; hs-CRP, high-sensitivity C-reactive protein; LDL-C, LDL cholesterol; WBC, white blood cell.

2

Calculated as weight in kilograms divided by height in meters squared.

3

Multiply by 0.02586 to convert cholesterol values to mmol/L and by 0.01129 to convert triglyceride to mmol/L.